Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain

American Journal of Gastroenterology

Volumn 105, Issue 5, 2010, Pages 1032-1038

  Kushnir, Vladimir M ^a   Sayuk, Gregory S ^a   Gyawali, C Prakash ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ACID EXPOSURE TIME; ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYMPTOM ASSOCIATION PROBABILITY; SYMPTOM INDEX; SYMPTOMATOLOGY; THORAX PAIN;

ANALYSIS OF VARIANCE; CHEST PAIN; COHORT STUDIES; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROTON PUMP INHIBITORS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951976279     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.646     Document Type: Article

References (26)

1. Faybush EM, Fass R. Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am 2004; 33: 41-54.
2. Vaezi MF. Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux diseases. Aliment Pharmacol Ther 2006; 23: 40-49
3. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting\a population-based study. Aliment Pharmacol Ther 2003; 17: 1115-1124
4. Ward BW, Wu WC, Richter JE et al. Long-term follow-up of symptomatic status of patients with noncardiac chest pain: is diagnosis of esophageal etiology helpful? Am J Gastroenterol 1987; 82: 215-218
5. Pandolfi no JE, Vela MF. Esophageal-reflux monitoring. Gastrointest Endosc, 2009; 69: 917-930
6. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102: 668-685
7. Richter JE. Chest pain and gastroesophageal reflux disease. J Clin Gastroenterol 2000; 30 (Suppl): S39-41.
8. Prakash C, Clouse RE. Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol 2006; 101: 446-452
9. Hersh MJ, Sayuk GS, Gyawali CP. Long-term outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough. J Clin Gastroenterol; e-pub ahead of print 12 October 2009.
10. Taghavi SA, Ghasedi M, Saberi-Firoozi M et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005; 54: 1067-1071
11. Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3: 329-334
12. Ghillebert G, Janssens J, Vantrappen G et al. Ambulatory 24 h intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 1990; 31: 738-744
13. Weusten BL, Roelofs JM, Akkermans LM et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-1745
14. Wiener GJ, Richter JE, Copper JB et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-361
15. Wang WH, Huang JQ, Zheng GF et al. Is proton pump inhibitor testing an eff ective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? A meta-analysis. Arch Intern Med 2005; 165: 1222-1228
16. Cremonini F, Wise J, Moayyedi P et al. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol 2005; 100: 1226-1232
17. Numans ME, Lau J, de Wit NJ et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004; 140: 518-527
18. Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 2008; 42: 867-874
19. Snedegar CT, Clouse RE. Comparison of reflux-associated symptom probability (RASP) tests from ambulatory pH monitoring. Gastroenterology 2004; 26 (Suppl 2): A-323.
20. Holinga JA, Kumar S, Prakash C et al. reflux-associated symptom probability from preoperative ambulatory pH monitoring predicts quality of life (QoL) following laparoscopic antireflux surgery. Gastroenterology 2007; 134 (Suppl 2): A-756.
21. Dekel R, Martinez-Hawthorne SD, Guillen RJ et al. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol 2004; 38: 24-29
22. Tutuian R, Mainie I, Agrawal A et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006; 130: 386-391
23. Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of factors predicting outcome aft er laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292-300.
24. Prakash C, Clouse RE. Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999; 44: 2373-2379
25. Achem SR. Noncardiac chest pain\treatment approaches. Gastroenterol Clin North Am 2008; 37: 859-878
26. Pandolfi no JE, Richter JE, Ours T et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-749